Sumanth Iyer

Drug-resistant EGFR lung cancer mutations promote tumor growth by stabilizing interfaces in ligand-free signaling-competent EGFR oligomers

F. Gervasio, M. Martin-Fernandez, S. Roberts, 2024, Biophysical Journal.